You are a patient or parent of a child diagnosed with Attention Deficit / Hyperactivity Disorder (ADHD) and your doctor has offered you treatment with Methylphenidate marketed as Concerta®, Quasym®, Medininet® or Ritalin®.
You want to access information about this drug that can enlighten you in your choices, know what are the expected effects, the risks associated with this prescription.
The National Agency for the Safety of Medicines has published a brochure specifically intended to inform patients and parents, as well as an analysis report providing an update on the prescription of methylphenidate in France.
We invite you to read these documents whose source is reliable.
Related posts:
Tunisia - IWatch denounces the embezzlement of the Ministry of Health
A caregiver who walked around wearing baggy clothes... I gave birth in the bed of my grandmother who...
Germany's Last Measures for Corona Come to an End Just in Time for Easter Holidays
1-Year-Old Baby Girl in China Diagnosed with Diabetes - Family Shocked
